Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00530010 · ClinicalTrials.gov registry record
Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
A clinical trial of Liver Cancer, sponsored by Northwestern University.
- Completed
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT00530010 is a study of Liver Cancer that has completed, run by Northwestern University. The registered enrollment target is 500 participants, above the 442-participant average among 78 other Liver Cancer trials with a reported enrollment target (13% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00530010, a study of Liver Cancer, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: Internal radiation therapy uses radioactive material placed directly into or near a tumor to kill tumor cells. Using radiolabeled glass beads to kill tumor cells may be effective treatment for liver cancer that cannot be removed by surgery. PURPOSE: This phase II trial is studying how well radiolabeled glass beads work in treating patients with liver cancer that cannot be removed by surgery.
Conditions Studied
Interventions
- RADIATION yttrium Y 90 glass microspheres
Study Locations (1)
Illinois
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2004-12 |
| Est. Completion | 2022-03-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00530010
The ClinicalTrials.gov registry entry for NCT00530010 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 442-participant average among 78 other Liver Cancer trials with a reported enrollment target (13% higher). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Liver Cancer appearing as the primary indexed condition, and to 1 intervention - of which yttrium Y 90 glass microspheres is the first listed.
NCT00530010 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT00530010 about?
NCT00530010 is a clinical study titled "Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery". RATIONALE: Internal radiation therapy uses radioactive material placed directly into or near a tumor to kill tumor cells. Using radiolabeled glass beads to kill tumor cells may be effective treatment for liver cancer that cannot be removed by surgery. PURPOSE: This phase II trial is studying how we...
What is the current status of trial NCT00530010?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2004-12. Estimated completion is 2022-03-08.
What conditions does trial NCT00530010 study?
This clinical trial studies the following conditions: Liver Cancer.
What interventions are being tested in trial NCT00530010?
The interventions under investigation include: yttrium Y 90 glass microspheres (RADIATION).
Who is sponsoring clinical trial NCT00530010?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00530010 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility Study of CBCT for IGRT in Cancer Patients
RECRUITING · NA
-
Collection of Blood From Patients With Cancer
RECRUITING
-
National Liver Cancer Screening Trial
RECRUITING · Phase 4
-
vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC
RECRUITING · NA
-
Multi-analyte Blood Test Clinical Trial
RECRUITING
-
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.